Abstract
Macronutrient metabolism is essential for transferring energy contained in food to usable forms of cellular energy. The balance between energy fuels flowing to cells and being released as cellular work will determine the body size. In the last decades, energy homeostasis has been challenged by an overwhelming macronutrient availability that imposes a need for further expansion of adipose mass. The capacity to handle such higher energy and macronutrient fluxes will determine metabolic disturbances (e.g., insulin resistance) at tissue and whole organism level. Herein, we reviewed carbohydrate, fat, and protein metabolism with special emphasis to the comparison between lean and obese individuals.
References
A Report of the Panel on Macronutrients, S. o. U. R. L. o. N. a. I. a. U. o. D. R. I.; the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, ed. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: The National Academies Press; 2002.
Aarsland A, Wolfe RR. Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men. J Lipid Res. 1998;39(6):1280-1286.
Abbott WG, Howard BV, et al. Short-term energy balance: relationship with protein, carbohydrate, and fat balances. Am J Physiol. 1988;255(3 Pt 1):E332-E337.
Acheson KJ, Schutz Y, et al. Glycogen storage capacity and de novo lipogenesis during massive carbohydrate overfeeding in man. Am J Clin Nutr. 1988;48(2):240-247.
Adeva-Andany M, Lopez-Ojen M, et al. Comprehensive review on lactate metabolism in human health. Mitochondrion. 2014;17:76-100.
Adiels M, Taskinen MR, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006;49(4):755-765.
Allenberg K, Nilsson M, et al. Glycogen and lactate synthetic pathways in human skeletal muscle in relation to obesity, weight reduction and physical training. Eur J Clin Invest. 1988;18(3):250-255.
Anastasiou CA, Kavouras SA, et al. Diabetes mellitus is associated with increased intramyocellular triglyceride, but not diglyceride, content in obese humans. Metabolism. 2009;58(11):1636-1642.
Badin PM, Louche K, et al. Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans. Diabetes. 2011;60(6):1734-1742.
Badin PM, Langin D, et al. Dynamics of skeletal muscle lipid pools. Trends Endocrinol Metab. 2013;24(12):607-615.
Baron AD, Brechtel G, et al. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol. 1988;255(6 Pt 1):E769-E774.
Baron AD, Laakso M, et al. Reduced postprandial skeletal muscle blood flow contributes to glucose intolerance in human obesity. J Clin Endocrinol Metab. 1990;70(6):1525-1533.
Bergman BC, Butterfield GE, et al. Evaluation of exercise and training on muscle lipid metabolism. Am J Physiol. 1999;276(1 Pt 1):E106-E117.
Bonadonna RC, Groop L, et al. Obesity and insulin resistance in humans: a dose–response study. Metabolism. 1990;39(5):452-459.
Bonen A, Parolin ML, et al. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 2004;18(10):1144-1146.
Bonen A, Chabowski A, et al. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda). 2007;22:15-29.
Bonuccelli S, Muscelli E, et al. Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms. Am J Physiol Endocrinol Metab. 2009;297(2):E532-E537.
Bosy-Westphal A, Kossel E, et al. Contribution of individual organ mass loss to weight loss-associated decline in resting energy expenditure. Am J Clin Nutr. 2009;90(4):993-1001.
Bray GA, Popkin BM. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes? Health be damned! Pour on the sugar. Diabetes Care. 2014;37(4):950-956.
Brosnan JT. Comments on metabolic needs for glucose and the role of gluconeogenesis. Eur J Clin Nutr. 1999;53(Suppl 1):S107-S111.
Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114(2):147-152.
Bruce AC, McNurlan MA, et al. Nutrient oxidation patterns and protein metabolism in lean and obese subjects. Int J Obes. 1990;14(7):631-646.
Caballero B, Wurtman RJ. Differential effects of insulin resistance on leucine and glucose kinetics in obesity. Metabolism. 1991;40(1):51-58.
Cahill GF Jr. Fuel metabolism in starvation. Annu Rev Nutr. 2006;26:1-22.
Chakravarthy MV, Lodhi IJ, et al. Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell. 2009;138(3):476-488.
Chevalier S, Marliss EB, et al. Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr. 2005;82(2):355-365.
Chevalier S, Burgess SC, et al. The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. Diabetes. 2006;55(3):675-681.
Chondrogianni N, Petropoulos I, et al. Protein damage, repair and proteolysis. Mol Aspects Med. 2014;35:1-71.
Cline GW, Petersen KF, et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med. 1999;341(4):240-246.
Coburn CT, Knapp FF Jr, et al. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem. 2000;275(42):32523-32529.
Coen PM, Goodpaster BH. Role of intramyocelluar lipids in human health. Trends Endocrinol Metab. 2012;23(8):391-398.
Despres JP. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients’ risk. Obes Res. 1998;6(Suppl 1):8S-17S.
Dohm GL, Tapscott EB, et al. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest. 1988;82(2):486-494.
Dunn JP, Abumrad NN, et al. Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Diabetes Care. 2012;35(1):137-142.
Egan B, Zierath JR. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 2013;17(2):162-184.
Everman S, Mandarino LJ, et al. Effects of acute exposure to increased plasma branched-chain amino acid concentrations on insulin-mediated plasma glucose turnover in healthy young subjects. PLoS One. 2015;10(3):e0120049.
Fabbrini E, Magkos F, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009;106(36):15430-15435.
Fabbrini E, Tamboli RA, et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology. 2010;139(2):448-455.
Ferrannini E, Bjorkman O, et al. The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes. 1985;34(6):580-588.
Ferreira LD, Pulawa LK, et al. Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance. Diabetes. 2001;50(5):1064-1068.
Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia. 2002;45(9):1201-1210.
Galgani JE, Ravussin E. Postprandial whole-body glycolysis is similar in insulin-resistant and insulin-sensitive non-diabetic humans. Diabetologia. 2012;55(3):737-742.
Galgani JE, Heilbronn LK, et al. Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate. Diabetes. 2008a;57(4):841-845.
Galgani JE, Moro C, et al. Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab. 2008b;295(5):E1009-E1017.
Galgani JE, Vasquez K, et al. Enhanced skeletal muscle lipid oxidative efficiency in insulin-resistant vs insulin-sensitive nondiabetic, nonobese humans. J Clin Endocrinol Metab. 2013;98(4):E646-E653.
Gan SK, Samaras K, et al. Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy. Diabetes. 2002;51(11):3163-3169.
Gavrilova O, Haluzik M, et al. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem. 2003;278(36):34268-34276.
Glatz JF, Luiken JJ, et al. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev. 2010;90(1):367-417.
Goldsmith R, Joanisse DR, et al. Effects of experimental weight perturbation on skeletal muscle work efficiency, fuel utilization, and biochemistry in human subjects. Am J Physiol Regul Integr Comp Physiol. 2010;298(1):R79-R88.
Goodpaster BH, He J, et al. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab. 2001;86(12):5755-5761.
Goodyear LJ, Giorgino F, et al. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest. 1995;95(5):2195-2204.
Goudriaan JR, Dahlmans VE, et al. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J Lipid Res. 2003;44(12):2270-2277.
Goudriaan JR, den Boer MA, et al. CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearance. J Lipid Res. 2005;46(10):2175-2181.
Greenhaff PL, Karagounis LG, et al. Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle. Am J Physiol Endocrinol Metab. 2008;295(3):E595-E604.
Guillet C, Delcourt I, et al. Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men. J Clin Endocrinol Metab. 2009;94(8):3044-3050.
Guo ZK, Cella LK, et al. De novo lipogenesis in adipose tissue of lean and obese women: application of deuterated water and isotope ratio mass spectrometry. Int J Obes Relat Metab Disord. 2000;24(7):932-937.
Hajri T, Abumrad NA. Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. Annu Rev Nutr. 2002;22:383-415.
Hawkins M, Gabriely I, et al. Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes. Diabetes. 2002;51(3):606-614.
Hellerstein MK, Schwarz JM, et al. Regulation of hepatic de novo lipogenesis in humans. Annu Rev Nutr. 1996;16:523-557.
Hill JO, Peters JC, et al. Nutrient balance in humans: effects of diet composition. Am J Clin Nutr. 1991;54(1):10-17.
Hoefler G, Noehammer C, et al. Muscle-specific overexpression of human lipoprotein lipase in mice causes increased intracellular free fatty acids and induction of peroxisomal enzymes. Biochimie. 1997;79(2–3):163-168.
Hojlund K, Birk JB, et al. Dysregulation of glycogen synthase COOH- and NH2-terminal phosphorylation by insulin in obesity and type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94(11):4547-4556.
Hoppeler H, Howald H, et al. Endurance training in humans: aerobic capacity and structure of skeletal muscle. J Appl Physiol. 1985;59(2):320-327.
Ibrahimi A, Bonen A, et al. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem. 1999;274(38):26761-26766.
Itani SI, Ruderman NB, et al. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes. 2002;51(7):2005-2011.
Javed F, He Q, et al. Brain and high metabolic rate organ mass: contributions to resting energy expenditure beyond fat-free mass. Am J Clin Nutr. 2010;91(4):907-912.
Jensen MD, Haymond MW. Protein metabolism in obesity: effects of body fat distribution and hyperinsulinemia on leucine turnover. Am J Clin Nutr. 1991;53(1):172-176.
Jensen DR, Schlaepfer IR, et al. Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. Am J Physiol. 1997;273(2 Pt 2):R683-R689.
Jing E, O’Neill BT, et al. Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes. 2013;62(10):3404-3417.
Kahn R, Sievenpiper JL. Response to comment on Kahn and Sievenpiper. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes? We have, but the pox on sugar is overwrought and overworked. Diabetes Care 2014;37:957-962. Diabetes Care 37(8):e189.
Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes. 2000;49(5):677-683.
Kelley DE, Goodpaster B, et al. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol. 1999a;277(6 Pt 1):E1130-E1141.
Kelley DE, Williams KV, et al. Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by PET. Am J Physiol. 1999b;277(2 Pt 1):E361-E369.
Kim JY, Hickner RC, et al. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab. 2000;279(5):E1039-E1044.
Kim JK, Fillmore JJ, et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A. 2001;98(13):7522-7527.
Krssak M, Falk Petersen K, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia. 1999;42(1):113-116.
Laakso M, Edelman SV, et al. Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes. 1990;39(8):965-974.
Lackey DE, Lynch CJ, et al. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab. 2013;304(11):E1175-E1187.
Lefort N, Glancy B, et al. Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle. Diabetes. 2010;59(10):2444-2452.
Levak-Frank S, Radner H, et al. Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J Clin Invest. 1995;96(2):976-986.
Lima MM, Pareja JC, et al. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers. Obesity (Silver Spring). 2013;21(3):E182-E189.
Liu L, Zhang Y, et al. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest. 2007;117(6):1679-1689.
Lovejoy J, Mellen B, et al. Lactate generation following glucose ingestion: relation to obesity, carbohydrate tolerance and insulin sensitivity. Int J Obes. 1990;14(10):843-855.
Lovejoy J, Newby FD, et al. Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin. Metabolism. 1992;41(1):22-27.
Luzi L, Castellino P, et al. Insulin and hyperaminoacidemia regulate by a different mechanism leucine turnover and oxidation in obesity. Am J Physiol. 1996;270(2 Pt 1):E273-E281.
Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol. 2014;10(12):723-736.
Matsusue K, Haluzik M, et al. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest. 2003;111(5):737-747.
Mayerson AB, Hundal RS, et al. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes. 2002;51(3):797-802.
McCormack SE, Shaham O, et al. Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr Obes. 2013;8(1):52-61.
McDevitt RM, Poppitt SD, et al. Macronutrient disposal during controlled overfeeding with glucose, fructose, sucrose, or fat in lean and obese women. Am J Clin Nutr. 2000;72(2):369-377.
McDevitt RM, Bott SJ, et al. De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women. Am J Clin Nutr. 2001;74(6):737-746.
McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51(1):7-18.
Meguid MM, Matthews DE, et al. Leucine kinetics at graded leucine intakes in young men. Am J Clin Nutr. 1986a;43(5):770-780.
Meguid MM, Matthews DE, et al. Valine kinetics at graded valine intakes in young men. Am J Clin Nutr. 1986b;43(5):781-786.
Minehira K, Vega N, et al. Effect of carbohydrate overfeeding on whole body macronutrient metabolism and expression of lipogenic enzymes in adipose tissue of lean and overweight humans. Int J Obes Relat Metab Disord. 2004;28(10):1291-1298.
Mizgier ML, Casas M, et al. Potential role of skeletal muscle glucose metabolism on the regulation of insulin secretion. Obes Rev. 2014;15(7):587-597.
Moro C, Galgani JE, et al. Influence of gender, obesity, and muscle lipase activity on intramyocellular lipids in sedentary individuals. J Clin Endocrinol Metab. 2009;94(9):3440-3447.
Muller MJ, Langemann D, et al. Effect of constitution on mass of individual organs and their association with metabolic rate in humans--a detailed view on allometric scaling. PLoS One. 2011;6(7):e22732.
Muller MJ, Wang Z, et al. Advances in the understanding of specific metabolic rates of major organs and tissues in humans. Curr Opin Clin Nutr Metab Care. 2013;16(5):501-508.
Muoio DM. Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock. Cell. 2014;159(6):1253-1262.
Nair KS, Garrow JS, et al. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia. 1983;25(5):400-403.
Newgard CB. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012;15(5):606-614.
Nielsen S, Guo Z, et al. Splanchnic lipolysis in human obesity. J Clin Invest. 2004;113(11):1582-1588.
Nielsen J, Mogensen M, et al. Increased subsarcolemmal lipids in type 2 diabetes: effect of training on localization of lipids, mitochondria, and glycogen in sedentary human skeletal muscle. Am J Physiol Endocrinol Metab. 2010;298(3):E706-E713.
Norgan NG. The beneficial effects of body fat and adipose tissue in humans. Int J Obes Relat Metab Disord. 1997;21(9):738-746.
Oral EA, Simha V, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346(8):570-578.
Owen OE, Mozzoli MA, et al. Oxidative and nonoxidative macronutrient disposal in lean and obese men after mixed meals. Am J Clin Nutr. 1992;55(3):630-636.
Parks EJ, Krauss RM, et al. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J Clin Invest. 1999;104(8):1087-1096.
Pelsers MM, Tsintzas K, et al. Skeletal muscle fatty acid transporter protein expression in type 2 diabetes patients compared with overweight, sedentary men and age-matched, endurance-trained cyclists. Acta Physiol (Oxf). 2007;190(3):209-219.
Poehlman ET, Toth MJ. Mathematical ratios lead to spurious conclusions regarding age- and sex-related differences in resting metabolic rate. Am J Clin Nutr. 1995;61(3):482-485.
Prentice AM, Goldberg GR, et al. Physiological responses to slimming. Proc Nutr Soc. 1991;50(2):441-458.
Promrat K, Lutchman G, et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology. 2004;39(1):188-196.
Ravikumar B, Carey PE, et al. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. Am J Physiol Endocrinol Metab. 2005;288(4):E789-E797.
Ravussin E, Galgani JE. The implication of brown adipose tissue for humans. Annu Rev Nutr. 2011;31:33-47.
Redman LM, Heilbronn LK, et al. Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss. PLoS One. 2009;4(2):e4377.
Rolfe DF, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev. 1997;77(3):731-758.
Rosenbaum M, Goldsmith R, et al. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest. 2005;115(12):3579-3586.
Rutkowski JM, Stern JH, et al. The cell biology of fat expansion. J Cell Biol. 2015;208(5):501-512.
Samocha-Bonet D, Dixit VD, et al. Metabolically healthy and unhealthy obese – the 2013 Stock Conference report. Obes Rev. 2014;15(9):697-708.
She P, Van Horn C, et al. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab. 2007;293(6):E1552-E1563.
Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371(23):2237-2238.
Sievenpiper JL, Chiavaroli L, et al. ‘Catalytic’ doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials. Br J Nutr. 2012;108(3):418-423.
Simha V, Szczepaniak LS, et al. Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. Diabetes Care. 2003;26(1):30-35.
Simoneau JA, Veerkamp JH, et al. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J. 1999;13(14):2051-2060.
Solini A, Bonora E, et al. Protein metabolism in human obesity: relationship with glucose and lipid metabolism and with visceral adipose tissue. J Clin Endocrinol Metab. 1997;82(8):2552-2558.
Speakman JR. Evolutionary perspectives on the obesity epidemic: adaptive, maladaptive, and neutral viewpoints. Annu Rev Nutr. 2013;33:289-317.
Speakman JR, Fletcher Q, et al. The ‘39 steps’: an algorithm for performing statistical analysis of data on energy intake and expenditure. Dis Model Mech. 2013;6(2):293-301.
Stanhope KL, Havel PJ. Fructose consumption: considerations for future research on its effects on adipose distribution, lipid metabolism, and insulin sensitivity in humans. J Nutr. 2009;139(6):1236S-1241S.
Stanhope KL, Schwarz JM, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119(5):1322-1334.
Stock MJ. Gluttony and thermogenesis revisited. Int J Obes Relat Metab Disord. 1999;23(11):1105-1117.
Stunff CL, Bougneres PF. Alterations of plasma lactate and glucose metabolism in obese children. Am J Physiol. 1996;271(5 Pt 1):E814-E820.
Swinburn B, Sacks G, et al. Increased food energy supply is more than sufficient to explain the US epidemic of obesity. Am J Clin Nutr. 2009;90(6):1453-1456.
Thorens B, Mueckler M. Glucose transporters in the 21st century. Am J Physiol Endocrinol Metab. 2010;298(2):E141-E145.
Timmers S, Nabben M, et al. Augmenting muscle diacylglycerol and triacylglycerol content by blocking fatty acid oxidation does not impede insulin sensitivity. Proc Natl Acad Sci U S A. 2012;109(29):11711-11716.
Trujillo ME, Scherer PE. Adipose tissue-derived factors: impact on health and disease. Endocr Rev. 2006;27(7):762-778.
Tschop MH, Speakman JR, et al. A guide to analysis of mouse energy metabolism. Nat Methods. 2012;9(1):57-63.
Virtue S, Vidal-Puig A. It’s not how fat you are, it’s what you do with it that counts. PLoS Biol. 2008;6(9):e237.
Voshol PJ, Jong MC, et al. In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes. 2001;50(11):2585-2590.
Walther TC, Farese RV Jr. Lipid droplets and cellular lipid metabolism. Annu Rev Biochem. 2012;81:687-714.
Wang Z, O’Connor TP, et al. The reconstruction of Kleiber’s law at the organ-tissue level. J Nutr. 2001;131(11):2967-2970.
Wang TJ, Larson MG, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17(4):448-453.
Welle S, Barnard RR, et al. Increased protein turnover in obese women. Metabolism. 1992;41(9):1028-1034.
Welle S, Statt M, et al. Differential effect of insulin on whole-body proteolysis and glucose metabolism in normal-weight, obese, and reduced-obese women. Metabolism. 1994;43(4):441-445.
Westerterp KR. Food quotient, respiratory quotient, and energy balance. Am J Clin Nutr. 1993;57(5 Suppl):59S-764S; discussion 764S-765S.
Weyer C, Vozarova B, et al. Changes in energy metabolism in response to 48 h of overfeeding and fasting in Caucasians and Pima Indians. Int J Obes Relat Metab Disord. 2001;25(5):593-600.
Yki-Jarvinen H, Mott D, et al. Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. J Clin Invest. 1987;80(1):95-100.
Young AA, Bogardus C, et al. Muscle glycogen synthesis and disposition of infused glucose in humans with reduced rates of insulin-mediated carbohydrate storage. Diabetes. 1988;37(3):303-308.
Zimmermann R, Strauss JG, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science. 2004;306(5700):1383-1386.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this entry
Cite this entry
Galgani, J.E., Cortés, V., Carrasco, F. (2016). Carbohydrate, Fat, and Protein Metabolism in Obesity. In: Ahima, R.S. (eds) Metabolic Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-319-11251-0_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-11251-0_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11250-3
Online ISBN: 978-3-319-11251-0
eBook Packages: MedicineReference Module Medicine